Baader Bank Aktiengesellschaft’s Novo Nordisk NVO Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$470K	Sell	9,800 -100	-1%	-$4.3K	0.04%	280
2026 Q1	$364K	Sell	9,900 -1,921	-16%	-$91K	0.03%	323
2025 Q4	$564K	Sell	11,821 -477	-4%	-$24.4K	0.04%	257
2025 Q3	$629K	Buy	12,298 +4,298	+54%	+$252K	0.04%	242
2025 Q2	$552K	Sell	8,000 -5,224	-40%	-$355K	0.04%	235
2025 Q1	$828K	Buy	13,224 +9,148	+224%	+$756K	0.06%	191
2024 Q4	$341K	Buy	+4,076	New	+$441K	0.02%	258

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Baader Bank Aktiengesellschaft's NVO Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft reduced its Novo Nordisk (NVO) stake by 1% in Q2 2026, selling an estimated $4.3K and leaving 9,800 shares worth $470K. The position accounts for 0.04% of the portfolio, ranked #280.

Baader Bank Aktiengesellschaft first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $828K in Q1 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Baader Bank Aktiengesellschaft held 9,800 shares of Novo Nordisk worth $470K as of Q2 2026.
Baader Bank Aktiengesellschaft sold 100 Novo Nordisk shares in Q2 2026, an estimated $4.3K.
Novo Nordisk made up 0.04% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #280 holding.
Baader Bank Aktiengesellschaft first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
Baader Bank Aktiengesellschaft's Novo Nordisk position peaked at $828K in Q1 2025.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.